{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:19:34Z","timestamp":1773058774323,"version":"3.50.1"},"reference-count":13,"publisher":"American Society for Microbiology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A high-throughput test to detect varicella-zoster virus (VZV) antibodies in varicella vaccine recipients is not currently available. One of the most sensitive tests for detecting VZV antibodies after vaccination is the fluorescent antibody to membrane antigen (FAMA) test. Unfortunately, this test is labor-intensive, somewhat subjective to read, and not commercially available. Therefore, we developed a highly quantitative and high-throughput luciferase immunoprecipitation system (LIPS) assay to detect antibody to VZV glycoprotein E (gE). Tests of children who received the varicella vaccine showed that the gE LIPS assay had 90% sensitivity and 70% specificity, a viral capsid antigen enzyme-linked immunosorbent assay (ELISA) had 67% and 87% specificity, and a glycoprotein ELISA (not commercially available in the United States) had 94% sensitivity and 74% specificity compared with the FAMA test. The rates of antibody detection by the gE LIPS and glycoprotein ELISA were not statistically different. Therefore, the gE LIPS assay may be useful for detecting VZV antibodies in varicella vaccine recipients. (This study has been registered at ClinicalTrials.gov under registration no. NCT00921999.)<\/jats:p>","DOI":"10.1128\/cvi.00250-14","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T03:19:31Z","timestamp":1404357571000},"page":"1288-1291","source":"Crossref","is-referenced-by-count":16,"title":["Detection of Antibodies to Varicella-Zoster Virus in Recipients of the Varicella Vaccine by Using a Luciferase Immunoprecipitation System Assay"],"prefix":"10.1128","volume":"21","author":[{"given":"Jeffrey I.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mir A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon P.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne A.","family":"Gershon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Burbelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2014,7,2]]},"reference":[{"key":"key20180919073743_B1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/infdis\/130.6.669","article-title":"Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence","volume":"130","author":"Williams","year":"1974","journal-title":"J. Infect. Dis."},{"key":"key20180919073743_B2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J. Infect. Dis."},{"key":"key20180919073743_B3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/501900","article-title":"Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers","volume":"22","author":"Saiman","year":"2001","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"key20180919073743_B4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","article-title":"The postmarketing safety profile of varicella vaccine","volume":"19","author":"Sharrar","year":"2000","journal-title":"Vaccine"},{"key":"key20180919073743_B5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/infdis\/136.4.519","article-title":"Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells","volume":"136","author":"Zaia","year":"1977","journal-title":"J. Infect. Dis."},{"key":"key20180919073743_B6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1128\/CVI.05130-11","article-title":"Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus","volume":"18","author":"Lafer","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073743_B7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jmv.1890320310","article-title":"Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen","volume":"32","author":"Wasmuth","year":"1990","journal-title":"J. Med. Virol."},{"key":"key20180919073743_B8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1128\/CVI.00183-12","article-title":"Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test","volume":"19","author":"Sauerbrei","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073743_B9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jviromet.2010.12.021","article-title":"Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers","volume":"172","author":"McDonald","year":"2011","journal-title":"J. Virol. Methods"},{"issue":"RR04","key":"key20180919073743_B10","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm. Rep."},{"key":"key20180919073743_B11","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1086\/529448","article-title":"Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccines and to screen for susceptibility to varicella","volume":"197","author":"Breuer","year":"2008","journal-title":"J. Infect. Dis."},{"key":"key20180919073743_B12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1128\/CVI.00350-08","article-title":"Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay","volume":"16","author":"Burbelo","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073743_B13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3349\/ymj.2014.55.2.459","article-title":"Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med. J."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00250-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:51:07Z","timestamp":1627591867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00250-14"}},"subtitle":[],"editor":[{"given":"S. A.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,2]]},"references-count":13,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,8,28]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1128\/CVI.00250-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00250-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,2]]}}}